Lessons Learned on Long-Acting ART: Implementation Insights From European Pioneers

The approvals of novel long-acting agents and regimens provide patients and healthcare professionals with additional options to consider when selecting the optimal ART regimen that will enable each individual to achieve sustained virologic success. Their novel methods of administration also require implementation of new approaches to minimize barriers to uptake, maximize patient satisfaction, and ensure timely dosing. This live, virtual symposium brings together a panel of pioneering European clinicians and a patient receiving long-acting ART to share their experiences, practical insights, and recommendations with peers who currently have less experience with injectable ART.


  • Introduction (5 min)
  • Panel Discussion (60 min): The panel will share their experiences and insights in 4 key areas.
    • Patient Candidacy
    • Administering LA-ART
    • Clinic Infrastructure
    • What the Future Holds
  • Question and Answer Session (25 min)


Date / Time
Event Details


Program Director
Olivia Jonsson-OldenbĂĽettel, MD, PhD

Medical Director
MVZ München am Goetheplatz
Munich, Germany

Stephane De Wit, MD, PhD

Former Head
Infectious Diseases
Saint Pierre University Hospital
Brussels, Belgium

Eric Florence, MD, PhD

Internal Medicine, Infectious Diseases & Tropical Medicine
University Hospital of Antwerp
Edegem, Brussels

Mireia SantaCreu Guerrero, MSN

Research Nurse/Study Coordinator
HIV Unit
Hospital 12 de Octubre
I+12 Investigation Institute Foundation
Madrid, Spain

Laurence Slama, MD, PhD

Department of Infectious Diseases
Hôtel Dieu, APHP
Paris, France


Patient receiving long-acting ART

Goal Statement
The goal of this activity is to improve healthcare professionals’ competence in integrating current and future long-acting ART agents into clinical practice, including strategies related to healthcare service delivery, patient counseling, and healthcare professional training.

Target Audience
This program is intended for physicians and other members of the healthcare team who provide care for patients with HIV infection.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Apply a thorough understanding of available data and real-world experience to ensure that long-acting ART is considered as a treatment strategy for patients for whom it may be appropriate
  • Integrate strategies to administer long-acting ART, support patient adherence to dosing visits, and minimize barriers to uptake and adverse events
  • Counsel colleagues and patients regarding potential future long-acting ART regimens and their anticipated availability


Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Designation of Credit

CCO designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.